DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: cancer treatment
News
04.09.2017
- US drugmaker Gilead Sciences has agreed to pay almost $12 billion to acquire compatriot Kite Pharma. Through the cash transaction, it will gain access to Car-T, Kite’s cutting-edge...
News
30.01.2017
- About 20% of all new drugs will be rationed under tighter cost-cutting plans in the UK’s National Service (NHS), according to reports, which suggest that patients who suffer from...
News
20.12.2016
- Proteros Biostructures has entered into a second research agreement with Merck Sharp & Dohme (known as MSD outside the US and Canada). The new collaboration is aimed at developing...
Markets & Companies
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
News
28.09.2015
- US pharmaceutical giant Pfizer has exercised its option under the companies’ global collaboration agreement to take an exclusive license from Bind Therapeutics for the purpose of...
News
13.06.2014
- Germany's Merck and compatriot biotech firm MorphoSys have agreed to cooperate on discovering and developing therapeutic antibodies against undisclosed immune checkpoints, that is...
News
05.06.2014
- Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...
News
25.04.2014
- AstraZeneca has unveiled plans to sell or partner infection and neuroscience units with combined 2013 sales of $3.5 billion and a basis in antibiotics and antipsychotics as well as...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.
